Publications in collaboration with researchers from Institució Catalana de Recerca i Estudis Avançats (19)

2024

  1. Backtracking NOM1::ETV6 fusion to neonatal pathogenesis of t(7;12) (q36;p13) infant AML

    Leukemia

  2. NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression

    Blood, Vol. 144, Núm. 19, pp. 2002-2017

2022

  1. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia

    Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919

  2. Robust in Vitro and in Vivo Immunosuppressive and Anti-inflammatory Properties of Inducible Caspase-9-mediated Apoptotic Mesenchymal Stromal/Stem Cell

    Stem Cells Translational Medicine, Vol. 11, Núm. 1, pp. 88-96

  3. The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia

    Cancers, Vol. 14, Núm. 6

2021

  1. Engraftment characterization of risk-stratified AML in NSGS mice

    Blood Advances, Vol. 5, Núm. 23, pp. 4842-4854

2020

  1. Bone marrow clonogenic myeloid progenitors from NPM1-mutated AML patients do not harbor the NPM1 mutation: Implication for the cell-of-origin of NPM1+ AML

    Genes, Vol. 11, Núm. 1

  2. Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells

    Molecular Therapy - Nucleic Acids, Vol. 20, pp. 196-204

2019

  1. Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis

    Haematologica, Vol. 104, Núm. 2, pp. e54-e58

  2. Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia

    Blood, Vol. 133, Núm. 21, pp. 2291-2304

  3. NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia

    Leukemia, Vol. 33, Núm. 7, pp. 1557-1569

2018

  1. Correction to: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL (Leukemia, (2018), 32, 3, (633-644), 10.1038/leu.2017.294)

    Leukemia

  2. Detection of inflammatory monocytes but not mesenchymal stem/stromal cells in peripheral blood of patients with myelofibrosis

    British Journal of Haematology

  3. IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML

    OncoImmunology, Vol. 7, Núm. 9

  4. NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL

    Leukemia, Vol. 32, Núm. 3, pp. 633-644

2017

  1. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes

    Stem Cell Reports, Vol. 8, Núm. 6, pp. 1573-1586

  2. Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease

    Experimental & molecular medicine, Vol. 49, Núm. 2, pp. e290

2016

  1. Cellular ontogeny and hierarchy influence the reprogramming efficiency of human B cells into induced pluripotent stem cells

    Stem Cells, Vol. 34, Núm. 3, pp. 581-587

  2. Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase

    Arthritis Research and Therapy, Vol. 18, Núm. 1